enVVeno Medical Corporati...

NASDAQ: NVNO · Real-Time Price · USD
4.64
0.14 (3.11%)
At close: Aug 15, 2025, 3:04 PM

enVVeno Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
812K 812K 812K 824K 824K 824K 824K n/a n/a n/a n/a n/a n/a n/a n/a 31.24K 31.24K 31.24K
Cost of Revenue
536K 542K 683K 411K 549K 551K 546K 542K 404K 399K 392K 383.59K 503.73K 478.23K 452.91K 331.32K 211.18K 103.68K
Gross Profit
147K 141K n/a 284K 275K 273K 278K -542K -404K -399K -392K -383.59K -503.73K -478.23K -452.91K -300.07K -179.94K -72.44K
Operating Income
-24.87M -23.28M -23.83M -23.41M -22.58M -23.94M -25.24M -25.42M -26.22M -26.39M -24.93M -27.46M -24.02M -19.42M -16.89M -12.06M -11.27M -10.43M
Interest Income
452K 330K 389K 278K 228K 194K 180K 172K 203K 201K 161K 117K 47K 10K 8K 8K 3K 3K
Pretax Income
-23.07M -21.33M -21.82M -21.24M -20.6M -22.12M -23.52M -24.05M -25.14M -25.73M -24.67M -27.48M -23.77M -19.08M -16.53M -11.91M -11.5M -10.75M
Net Income
-23.07M -21.33M -21.82M -21.24M -20.6M -22.12M -22.75M -22.81M -23.9M -24.49M -24.2M -27.48M -23.77M -19.08M -16.53M -11.91M -11.5M -10.75M
Selling & General & Admin
12.92M 11.39M 11.3M 11.28M 10.52M 10.62M 11.52M 12.02M 13.12M 14.44M 15.02M 18.57M 16.39M 13.77M 11.16M 5.84M 5.52M 5.06M
Research & Development
11.82M 11.75M 12.25M 11.72M 11.66M 13.04M 13.59M 13.4M 13.1M 11.96M 9.91M 8.9M 7.63M 5.65M 5.73M 6.22M 5.76M 5.37M
Other Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 867.00 33.27K 33.27K 33.27K 32.41K
Operating Expenses
25.02M 23.42M 23.83M 22.99M 22.17M 23.67M 25.1M 25.42M 26.22M 26.39M 24.93M 27.46M 24.02M 19.42M 16.89M 12.06M 11.27M 10.43M
Interest Expense
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
25.55M 23.96M 24.51M 23.41M 22.58M 23.94M 25.24M 25.42M 26.22M 26.39M 24.93M 27.46M 24.02M 19.42M 16.89M 12.06M 11.27M 10.43M
Income Tax Expense
n/a n/a n/a n/a n/a n/a -765K -1.24M -1.29M -1.29M -528K -54K n/a -6.7K -9.66K -9.97K -9.97K -3.27K
Shares Outstanding (Basic)
20.35M 20.35M 20.38M 16.07M 16.07M 16.06M 13.32M 11.23M 11.23M 11.23M 9.47M 11.23M 11.23M 11.23M 11.2M 9.18M 8.51M 5.74M
Shares Outstanding (Diluted)
20.35M 20.35M 20.38M 16.07M 16.07M 16.06M 13.32M 11.23M 11.23M 11.23M 9.47M 11.23M 11.23M 11.23M 11.2M 9.18M 8.51M 5.74M
EPS (Basic)
0.01 0.03 -0.06 -1.39 -1.49 -1.76 -1.95 -2.13 -2.22 -2.27 -2.24 -2.44 -2.16 -1.81 -1.82 -2.74 -3.85 -5.46
EPS (Diluted)
0.01 0.03 -0.06 -1.39 -1.49 -1.76 -1.95 -2.13 -2.22 -2.27 -2.24 -2.44 -2.16 -1.81 -1.82 -2.74 -3.85 -5.46
EBITDA
-24.14M -22.89M -23.3M -22.86M -22.04M -23.39M -24.69M -24.88M -25.68M -25.86M -24.41M -26.94M -23.63M -19.06M -16.56M -11.75M -10.87M -10.03M
EBIT
-24.52M -23.28M -23.83M -23.41M -22.58M -23.94M -25.24M -25.42M -26.22M -26.39M -24.93M -27.46M -24.02M -19.42M -16.89M -12.06M -11.27M -10.43M
Depreciation & Amortization
503K 509K 528K 540K 549K 551K 546K 542K 537K 532K 525K 516.59K 503.73K 478.23K 452.91K 427.3K 405.7K 401.59K